GHK-Cu is a small copper-binding peptide, the amino acids glycine, histidine and lysine joined together and holding a copper ion, that occurs naturally in blood and skin and falls with age. On the skin it is sold in serums and creams for firmness, fine lines and repair, and the case for that use rests mostly on laboratory and animal work: GHK-Cu raises collagen and other matrix production in cultured skin cells and speeds matrix buildup in animal wounds. The human evidence is thin. The one randomized facial trial, in people healing from laser resurfacing, found no measured improvement in wrinkles or redness against the same routine without it, though those patients rated their own skin as better.
Much of the enthusiastic literature comes from the researcher who developed and sells the peptide, so weigh it accordingly. Applied to intact skin it is generally well tolerated. Injected or taken to act through the whole body it is a different question: that use has not been tested in people, is sold through grey-market channels, and its safety at those doses is unknown. This page covers the topical use and gives no injection protocol.
Findings & Outcomes
What It Is
GHK-Cu is a copper-binding tripeptide: three amino acids, glycine, histidine and lysine, linked in a short chain that grips a single copper ion. The peptide part, GHK, is made in the body and circulates in blood, saliva and urine; the level in plasma is around 200 nanograms per milliliter in young adults and drops by roughly two thirds by age sixty. It binds copper tightly, and the copper-loaded form is what most of the research studies.
In skin care it appears in serums, creams and eye products under names like copper tripeptide-1 and GHK-Cu, usually at a fraction of a percent. It is marketed for firmer skin, softer fine lines, and faster repair after irritation or a cosmetic procedure. Weaker cosmetic relatives exist, including a copper complex of the peptide AHK.
Two routes need to be kept apart. Applied to the skin, GHK-Cu is a cosmetic ingredient with a mechanism worth taking seriously and a small, mixed human record. Injected under the skin or into muscle, or taken to act through the whole body, it is a grey-market practice with no controlled human evidence of benefit and no established safety, and this page does not cover dosing for it.
What It Does
The findings sit at different strengths, and they are graded separately below. The strong part is the cell and animal work; the human part is thin.
In cultured skin cells GHK-Cu raises the output of collagen and other components of the tissue scaffold, and it supports the fibroblasts that build that scaffold. In animals the signal is repair. Injected into wound chambers under the skin of rats, GHK-Cu produced a dose-dependent rise in collagen, protein, DNA and glycosaminoglycan content, with collagen synthesis climbing about twice as fast as other proteins. A biotinylated form of the peptide, carried in a collagen dressing, sped wound contraction and matrix buildup in diabetic rats. Not every animal result agrees: one guinea-pig study of the same complex found slower skin reorganization and delayed fibroblast activation alongside the increase in collagen expression, so the wound-repair picture in living tissue is not uniform.
The human record is where the popular version overreaches. The one randomized, blinded facial trial gave GHK-Cu skin-care products or the same routine without the peptide to thirteen patients healing from carbon-dioxide laser resurfacing. Blinded raters and computer analysis found no advantage in clearing redness, and no measured improvement in wrinkles or overall skin quality; the only edge was that patients using GHK-Cu rated their own skin higher on a questionnaire. Larger cosmetic-firmness studies are cited in marketing material, but they are mostly industry documents rather than peer-reviewed trials, and a fair reading is that the topical benefit in people is plausible and under-tested rather than shown.
Much of the most confident writing on GHK-Cu comes from the scientist who discovered the peptide and founded the company that sells it, and several of the widely cited review papers share that authorship. That does not make the biology wrong, but it is a reason to lean on the raw cell and animal data and to treat the strongest claims with care.
Hair is the thinnest area. The follicle study most often cited in support tested AHK-Cu, a related copper tripeptide and not GHK-Cu itself; it lengthened human hair follicles and helped dermal papilla cells in the dish. Direct evidence that topical GHK-Cu grows hair in people is lacking.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
How it works
GHK-Cu stimulates collagen and matrix synthesis in cultured skin fibroblasts
In lab dishes, GHK-Cu prompts skin cells to make more collagen and other building blocks of firm skin.
In cultured human skin fibroblasts, the tripeptide-copper complex GHK-Cu increased collagen synthesis, an effect first reported by Maquart and colleagues and repeatedly described since. GHK-Cu also raises production of elastin and glycosaminoglycans and supports fibroblast function, and copper is a required cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin into firm tissue. Measured in: Cultured human dermal fibroblasts. This is cell-culture work; a mechanism shown in a dish does not establish that a topical serum produces a visible change in a person's skin.
The studies · 2
Maquart et al., Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex GHK-Cu · FEBS Lett 1988;238(2):343-346
Pickart et al., GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration · Biomed Res Int 2015;2015:648108
GHK binds a reactive lipid-breakdown product in vitro, a modest antioxidant action
In a test tube, GHK mops up a damaging molecule made when skin fats break down, though it does this more weakly than carnosine.
In physiological buffer, the tripeptide GHK quenched the cytotoxic lipid-peroxidation product 4-hydroxy-2-nonenal (HNE) by forming a GHK-HNE adduct, confirmed by mass spectrometry and NMR, but it was significantly less potent than the reference antioxidant peptide carnosine. Reviews of gene-expression data describe GHK influencing a broad set of repair, antioxidant and inflammation-related pathways. Measured in: Cell-free physiological buffer assays and gene-expression reviews. This is a test-tube chemistry result and gene-expression review, not a measured antioxidant benefit in human skin; the effect was weaker than the comparator.
The studies · 2
Beretta et al., Glycyl-histidyl-lysine (GHK) is a quencher of alpha,beta-4-hydroxy-trans-2-nonenal · Chem Res Toxicol 2007;20(9):1309-1314
Pickart et al., The human tri-peptide GHK and tissue remodeling · J Biomater Sci Polym Ed 2008;19(8):969-988
Skin And Hair
GHK-Cu increased connective-tissue and collagen accumulation and sped wound repair in animal models
In rats, GHK-Cu applied to wounds built up more collagen and repair tissue and, in a diabetic-rat model, closed wounds faster than no treatment.
In rat subcutaneous wound chambers, sequential injection of GHK-Cu produced a concentration-dependent increase in dry weight, DNA, total protein, collagen and glycosaminoglycan content, with collagen synthesis stimulated about twice as much as noncollagen protein, and type I and III collagen mRNA raised, while an inactive control tripeptide had no effect. In streptozotocin-diabetic rats, a biotinylated GHK peptide carried in a collagen matrix increased the rate of wound contraction and raised collagen, protein and DNA in granulation tissue versus untreated and plain-collagen controls. Measured in: Rat subcutaneous wound chambers and streptozotocin-induced diabetic rat skin wounds. These are animal wound models, not human trials; one guinea-pig study of the same complex found slower skin reorganization and delayed fibroblast activation, so the repair effect in living tissue is not uniform.
The studies · 2
Maquart et al., In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex GHK-Cu in rat experimental wounds · J Clin Invest 1993;92(5):2368-2376
Arul et al., A therapeutic approach for diabetic wound healing using biotinylated GHK incorporated collagen matrices · Life Sci 2007;80(4):275-284
Topical GHK-Cu did not improve measured wrinkles or redness after laser resurfacing, though patients rated their skin higher
In the one randomized facial trial, people healing from laser resurfacing who used GHK-Cu products saw no measured improvement in wrinkles or redness over the same routine without it, though they rated their own skin as better.
In a randomized trial, 13 patients healing from circumoral carbon-dioxide laser resurfacing used a post-treatment regimen with or without GHK-Cu skin-care products. Blinded evaluators and computer analysis found no statistically significant difference between groups in the resolution of erythema, and no significant improvement in wrinkles or overall skin quality at 12 weeks. Patient-reported satisfaction with overall skin quality was higher in the GHK-Cu group (P = 0.04). Measured in: 13 adults completing a post-CO2-laser-resurfacing regimen. The trial was very small at 13 completers and tested products on freshly resurfaced skin rather than routine aging, so it neither confirms nor rules out a cosmetic benefit; the only positive was subjective patient rating.
The study · 1
Miller et al., Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin · Arch Facial Plast Surg 2006;8(4):252-259
A related copper tripeptide lengthened human hair follicles in the lab; direct GHK-Cu hair evidence in people is lacking
A cousin copper peptide made human hair follicles grow longer in the lab, but this was not GHK-Cu, and no good study shows GHK-Cu grows hair in people.
The copper tripeptide AHK-Cu (L-alanyl-L-histidyl-L-lysine-Cu) stimulated elongation of human hair follicles ex vivo and the proliferation of cultured dermal papilla cells at picomolar-to-nanomolar concentrations, and shifted apoptosis markers in papilla cells. The study tested AHK-Cu, a relative of GHK-Cu, not GHK-Cu itself, and there is no controlled trial showing topical GHK-Cu grows hair in people. Measured in: Excised human hair follicles and cultured human dermal papilla cells. The follicle study used AHK-Cu rather than GHK-Cu, was done on excised follicles and cultured cells, and does not establish a hair-growth effect from a GHK-Cu product on a person.
The study · 1
Pyo et al., The effect of tripeptide-copper complex on human hair growth in vitro · Arch Pharm Res 2007;30(7):834-839
How It Works
Two mechanisms are proposed, and they fit together. The first is copper delivery. Copper is a required cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin into firm tissue, and GHK carries copper in a form cells can take up. The second is signaling. GHK, with or without copper, shifts which genes skin cells read: it raises the synthesis of collagen, elastin and glycosaminoglycans, supports fibroblasts, and in reviews of gene-expression data influences a broad set of repair and inflammation pathways. GHK also acts as a modest antioxidant, binding the reactive lipid-breakdown product 4-hydroxynonenal in a test tube, though less strongly than carnosine.
GHK-Cu does not sand skin from the outside. It supplies copper and shifts the behavior of the living cells underneath toward building matrix, which is why any visible change is slow and why the mechanism is clearer than the human results.
Anatomy of the Practice
1In the first days
On intact skin a serum delivers the peptide and its copper into the upper layers. Nothing visible happens quickly. In wounded or freshly resurfaced tissue this is when the cell work matters most, and the animal data show matrix proteins beginning to accumulate over days rather than hours.
2Over weeks
The proposed benefit is a gradual rise in collagen and other scaffold material as fibroblasts respond, the same slow rebuilding that any collagen-directed treatment depends on. This is the window the cosmetic products are used across, and it is also where the human evidence thins out, because few controlled trials have measured it.
3The ceiling
GHK-Cu supplies a cofactor and a signal; it does not replace the proven drivers of skin aging. Sun protection, not smoking, and a topical retinoid have far stronger human evidence, and GHK-Cu at best works at the edges of what those provide.
How to Use It
Ways to Do It
GHK-Cu is a cosmetic add-on, not a foundation. The things with the strongest human evidence for skin cost little or nothing and come first; a copper-peptide serum is an optional layer on top, and injectable use is left off entirely because it has not been tested in people and its safety is unknown. Start at the first rung.
Daily broad-spectrum sunscreen, not smoking, and sleep do more for skin firmness and fine lines than any peptide, and they are free or nearly so. A prescription or over-the-counter retinoid has the strongest human evidence of any topical for sun-aged skin. If you do only one thing, it is sunscreen, and if you add one active, a retinoid has more behind it than a copper peptide.
A GHK-Cu or copper tripeptide-1 serum, applied to clean skin once or twice a day, is the ordinary way to use it. Introduce it on its own for a week or two to check your skin tolerates it before layering it with other actives. Judge it over months, not weeks, and keep expectations modest given how thin the human evidence is.
If you want to combine it with a retinoid, use them at different times of day, since low pH and strong oxidizers can pull copper off the peptide and some retinoid formulas are acidic. Patch test any new pairing. There is no reason to chase high concentrations; the ingredient is used at low percentages, and more has not been shown to do more.
Go Deeper
- Tretinoin: the topical with the strongest human evidence for sun-aged skin and acne, the one to reach for before a copper peptide.
- Skin and hair: the goal page that gathers what actually moves skin firmness, texture and hair, ranked by how strong the evidence is.
- Collagen supplements: the other collagen-branded product, with its own small and mostly industry-funded human record.
- Vitamin C: the topical antioxidant most often paired with sunscreen, with a longer research trail than copper peptides.
- BPC-157: the injected healing peptide sold on the same recovery promise, where rodent research runs well ahead of any human trial.
The Chinese Medicine View
Chinese medicine has no counterpart to a synthetic copper peptide, and it is more accurate to say so than to build a bridge that is not there. The tradition treats the skin from the inside, reading dullness, dryness and slow healing through patterns such as Blood deficiency, Blood dryness, or a weak Spleen failing to nourish the flesh, and it works through diet, herbs and lifestyle rather than a topical that reprograms skin cells. A lab-made tripeptide sits outside that framework.
Where the two frames touch is caution, not mechanism. A practitioner reading a person as Blood deficient, with dry skin and thin, slow-growing hair, would treat the underlying pattern and would not expect a surface product to substitute for that. Copper appears in the classical materia medica only as a mineral used in specific, limited ways, and nothing in the tradition anticipated this molecule. If you have a practitioner, slow healing or thinning hair is worth raising with them, because the pattern behind it is what they would treat.
Cautions For This Practice
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Injected or systemic GHK-Cu has no controlled human evidence of benefit and no established safety
Published GHK-Cu research in people is limited to topical and formulation contexts and small cosmetic or post-procedure use; the regenerative and protective actions summarized in reviews rest on cell, animal and gene-expression data. No controlled human trials establish benefit or safety for injected, subcutaneous or otherwise systemic GHK-Cu, which is distributed through grey-market and research-chemical channels without manufacturing oversight. This reflects an absence of human trials for systemic use rather than a measured harm; unmonitored copper exposure and unverified product purity are the specific concerns.Pickart & Margolina, Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Do not inject it or take it to act through the body
Injected under the skin or into muscle, or taken to work systemically, GHK-Cu has no controlled human evidence of benefit and no established safety at those doses. It is sold through grey-market and research-chemical channels with no manufacturing oversight, so purity, dose and contamination are unknown. Extra copper in the body is not harmless; the safe topical record does not carry over to injection. Nothing on this page should be read as a dosing protocol for that use.
Expect irritation to be possible on skin
Topical GHK-Cu is generally well tolerated, but any leave-on product can cause redness, stinging or an allergic contact reaction, and copper itself can sensitize some people. Introduce it alone, patch test on the inner forearm first, and stop if you get persistent redness, itching or swelling rather than pushing through.
Keep it off open wounds and eyes unless a clinician directs it
Cosmetic serums are made for intact skin. Do not put a skin-care product into an open wound, a fresh surgical site, or the eyes on your own; wound and post-procedure care belongs with the clinician managing it.
Be conservative in pregnancy and breastfeeding
There is little to no safety data on topical GHK-Cu in pregnancy or breastfeeding. Skin absorption of a low-concentration peptide is likely small, but with no evidence either way the cautious choice is to skip optional cosmetic actives during this time, or to ask your clinician first.
It is an add-on, not a treatment
Do not use a copper peptide in place of care that works. Sun protection and a retinoid have far stronger evidence for aging skin, and thinning hair, non-healing wounds or a changing mole need a clinician rather than a serum.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
Common Questions
Does GHK-Cu actually reduce wrinkles?
The mechanism is real and the marketing is ahead of the human evidence. In cells and animals GHK-Cu raises collagen and matrix production, but the one randomized facial trial, in people healing from laser resurfacing, found no measured improvement in wrinkles or redness against the same routine without it. Larger firmness studies exist mostly as industry documents rather than peer-reviewed trials. Treat it as a plausible, under-tested add-on, and put sunscreen and a retinoid first.
Is injecting or taking GHK-Cu safe?
There is no controlled human evidence for injected or systemic GHK-Cu, and its safety at those doses is unknown. It is sold through grey-market channels with no manufacturing oversight, so what is in the vial is unverified. The reassuring record for topical use does not transfer to injection, and extra copper in the body carries its own risks. This is the part of the topic to leave alone.
Can it regrow hair?
The evidence for hair is very thin, and the study usually cited for it tested AHK-Cu, a related copper peptide and not GHK-Cu, which lengthened human hair follicles in a dish. No good trial shows topical GHK-Cu growing hair in people. If hair loss matters to you, minoxidil and finasteride have real human evidence and are the better place to start.
How does it compare with a retinoid or vitamin C?
A retinoid has the strongest human evidence of any topical for sun-aged skin, and vitamin C paired with sunscreen has a longer research trail than copper peptides. GHK-Cu sits below both on the strength of human data. It can be a layer in a routine, but it is not a substitute for the actives that have been tested more.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 9 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 10, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.